Search research articles
Contact Us
Filters
Showing results (261-270 of 267) with videos related to
Page
of 27
Sort By:
You have reached the last page of results.
This site can display upto 267 results.
Terapevticheskii Arkhiv
|
November 2, 2006
[Exercise in outpatient complex rehabilitation and secondary prophylaxis in patients with ischemic heart disease after acute coronary events (a cooperative trial in Russia)]
D M Aronov, V B Krasnitskiĭ, M G Bubnova, et al.
Journal of Medicinal Chemistry
|
July 8, 2016
Fragment-Based Discovery of Dual JC Virus and BK Virus Helicase Inhibitors
Dominique Bonafoux, Suganthini Nanthakumar, Upul K Bandarage, et al.
Molecular Cancer Therapeutics
|
September 24, 2017
Targeting the MAPK Signaling Pathway in Cancer: Promising Preclinical Activity with the Novel Selective ERK1/2 Inhibitor BVD-523 (Ulixertinib)
Ursula A Germann, Brinley F Furey, William Markland, et al.
Journal of Medicinal Chemistry
|
October 16, 2009
Structure-guided design of potent and selective pyrimidylpyrrole inhibitors of extracellular signal-regulated kinase (ERK) using conformational control
Alex M Aronov, Qing Tang, Gabriel Martinez-Botella, et al.
Journal of Medicinal Chemistry
|
June 30, 2015
Discovery of Highly Isoform Selective Thiazolopiperidine Inhibitors of Phosphoinositide 3-Kinase γ
Philip N Collier, David Messersmith, Arnaud Le Tiran, et al.
Kardiologiia
|
March 5, 2009
[Physical training at ambulatory-polyclinical stage in complex rehabilitation and secondary prevention of patients with ischemic heart disease after acute incidents. Effect on physical working capacity, hemodynamics, blood lipids, clinical course and prognosis (Russian cooperative study)]
D M Aronov, V B Krasnitskiĭ, M G Bubnova, et al.
Journal of Medicinal Chemistry
|
May 31, 2018
Design and Synthesis of a Novel Series of Orally Bioavailable, CNS-Penetrant, Isoform Selective Phosphoinositide 3-Kinase γ (PI3Kγ) Inhibitors with Potential for the Treatment of Multiple Sclerosis (MS)
Jon H Come, Philip N Collier, James A Henderson, et al.
Page
of 27
Search research articles
Search
Showing results (261-270 of 267) with videos related to
Sort By:
Page
of 27
You have reached the last page of results.
This site can display upto 267 results.
Terapevticheskii Arkhiv
|
November 2, 2006
[Exercise in outpatient complex rehabilitation and secondary prophylaxis in patients with ischemic heart disease after acute coronary events (a cooperative trial in Russia)]
D M Aronov, V B Krasnitskiĭ, M G Bubnova, et al.
Journal of Medicinal Chemistry
|
July 8, 2016
Fragment-Based Discovery of Dual JC Virus and BK Virus Helicase Inhibitors
Dominique Bonafoux, Suganthini Nanthakumar, Upul K Bandarage, et al.
Molecular Cancer Therapeutics
|
September 24, 2017
Targeting the MAPK Signaling Pathway in Cancer: Promising Preclinical Activity with the Novel Selective ERK1/2 Inhibitor BVD-523 (Ulixertinib)
Ursula A Germann, Brinley F Furey, William Markland, et al.
Journal of Medicinal Chemistry
|
October 16, 2009
Structure-guided design of potent and selective pyrimidylpyrrole inhibitors of extracellular signal-regulated kinase (ERK) using conformational control
Alex M Aronov, Qing Tang, Gabriel Martinez-Botella, et al.
Journal of Medicinal Chemistry
|
June 30, 2015
Discovery of Highly Isoform Selective Thiazolopiperidine Inhibitors of Phosphoinositide 3-Kinase γ
Philip N Collier, David Messersmith, Arnaud Le Tiran, et al.
Kardiologiia
|
March 5, 2009
[Physical training at ambulatory-polyclinical stage in complex rehabilitation and secondary prevention of patients with ischemic heart disease after acute incidents. Effect on physical working capacity, hemodynamics, blood lipids, clinical course and prognosis (Russian cooperative study)]
D M Aronov, V B Krasnitskiĭ, M G Bubnova, et al.
Journal of Medicinal Chemistry
|
May 31, 2018
Design and Synthesis of a Novel Series of Orally Bioavailable, CNS-Penetrant, Isoform Selective Phosphoinositide 3-Kinase γ (PI3Kγ) Inhibitors with Potential for the Treatment of Multiple Sclerosis (MS)
Jon H Come, Philip N Collier, James A Henderson, et al.
Page
of 27